Fundz

Joshua Ziel, Ph.D., Appointed as Chief Executive Officer of Bryn Pharma, LLC

PRIVATEOct 24, 2024

Position

Chief Executive Officer

Company

Bryn Pharma

Joshua Ziel
jziel@brynpharma.com
New JerseyManufacturingHealthcareHealth Care

Description

Bryn Pharma, LLC has announced the appointment of Joshua Ziel, Ph.D., as the Chief Executive Officer and member of the Board of Directors. This appointment comes as Sandy Loreaux, former CEO, steps down for family-related reasons but will continue to serve on the Board of Directors to guide company strategy.

Quick answer

Joshua Ziel, Ph.D., Appointed as Chief Executive Officer of Bryn Pharma, LLC (October 24, 2024). Bryn Pharma is based in New Jersey, United States.

Who is the new Chief Executive Officer at Bryn Pharma?
Bryn Pharma named Joshua Ziel Chief Executive Officer, announced October 24, 2024.
What did Bryn Pharma announce on October 24, 2024?
Bryn Pharma, LLC has announced the appointment of Joshua Ziel, Ph.D., as the Chief Executive Officer and member of the Board of Directors. This appointment comes as Sandy Loreaux, former CEO, steps down for family-related reasons but will continue to serve on the Board of Directors to guide company strategy.
What does Bryn Pharma do?
Bryn Pharma is a privately held pharmaceutical company based in North Carolina, focused on developing and commercializing innovative allergy treatments for managing anaphylaxis.
Where is Bryn Pharma based?
Bryn Pharma is based in New Jersey, United States.
Which similar companies made leadership changes around the same time?
TransMedics Group (November 1, 2024), Century Therapeutics (September 27, 2024), Treace (December 2, 2024) and Crown Laboratories (October 23, 2024) also announced leadership changes within 45 days of Bryn Pharma.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Manufacturing

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Bryn Pharma, and when

A new leader at Bryn Pharma brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Bryn Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Bryn Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Bryn Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Bryn Pharma

Location

26 STILL HOLLOW RD

New Jersey, United States

About

Bryn Pharma is a privately held pharmaceutical company based in North Carolina, focused on developing and commercializing innovative allergy treatments for managing anaphylaxis. Its mission is to empower patients with a life-saving device that fits comfortably in a pocket and is easy to use during an anaphylactic attack. The company’s intranasal delivery system offers a needle-free, portable, and affordable alternative to epinephrine auto-injectors.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Bryn Pharma changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Michelle
Senior decision-maker at this company
••••••••@••••••••

See Michelle's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Bryn Pharma's next move

Learn about Strategic plan

Bryn Pharma changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.